Jefferies Group LLC Spectrum Pharmaceuticals Inc Transaction History

Jefferies Group LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.63 - $1.59 $79,814 - $201,435	-126,689 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.27 - $2.42 $160,895 - $306,587	126,689 New	126,689 $58,000
Q1 2020 May 15, 2020	SELL	$1.83 - $3.45 $91,500 - $172,500	-50,000 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$3.5 - $10.35 $136,076 - $402,397	38,879 Added 349.6%	50,000 $182,000
Q3 2019 Nov 13, 2019	BUY	$7.03 - $9.7 $78,180 - $107,873	11,121 New	11,121 $92,000
Q1 2019 May 15, 2019	SELL	$9.08 - $11.84 $193,158 - $251,872	-21,273 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$6.39 - $16.99 $50,947 - $135,461	7,973 Added 59.95%	21,273 $186,000
Q3 2018 Nov 14, 2018	BUY	$16.52 - $24.82 $219,716 - $330,106	13,300 New	13,300 $223,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.